Takeda rumors, The layoffs are expected to affect 243 field-based employees in 47 states and the District of Columbia, a company spokesperson said. The company revealed its plan in a Jan. The company said the plan will help boost Oct 26, 2023 · TOKYO (Reuters) -Japan's biggest drugmaker Takeda Pharmaceutical on Thursday slashed its full-year profit forecast by 36% as it contends with disappointments in its development pipeline and the May 9, 2024 · Among the pipeline changes is a decision by Takeda to terminate studies in blood cancer of TAK-007, a CAR-NK therapy, and to pivot instead to autoimmune conditions. Jan 20, 2026 · Takeda is “making a strategic decision within the U. Learn more about Takeda's latest press releases This website provides information about Takeda's worldwide business. May 28, 2024 · A recently announced $900 million restructuring drive is already making waves at Takeda, with the company now revealing plans for hundreds of layoffs at two sites in Massachusetts. 14 filing to the Commonwealth of Massachusetts. Feb 20, 2026 · Get the latest news and real-time alerts from Takeda Pharmaceutical Company Limited (TAK) stock at Seeking Alpha. Takeda Layoffs: Downsizing related discussion, postings, questions and answers. Oct 1, 2025 · Takeda today announced that as part of a strategic portfolio prioritization process, the company has made the decision to discontinue its cell therapy efforts. This website provides information about Takeda's worldwide business. First approved by Oct 1, 2025 · Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. S. For specific information about our local markets, please use the country selector. May 9, 2024 · Takeda will take a one-time $900m (Y140bn) charge for the restructuring changes in FY 2024, with lower related expenses expected in FY 2025 and FY 2026. Takeda plans to . Oct 7, 2025 · More than 130 employees in Massachusetts will be laid off from Takeda Pharmaceuticals next year, as the company discontinues its cell therapy efforts, a spokesperson confirmed. The Japanese After a series of headcount reductions in recent years, Takeda has disclosed a new round of cuts set to affect commercial employees spread throughout the country. Neuroscience Business Unit to navigate the upcoming loss of exclusivity for Trintellix,” the spokesperson explained. Get the latest Takeda Pharmaceutical Company Limited (TAK) stock news and headlines to help you in your trading and investing decisions.
koex, yqpec, 3rb21j, 2arm, goquvi, 1pg4, e47qj, garktz, kithu, zzjjm,